US Patent 9963702 RNA interference in dermal and fibrotic indications
Patent 9963702 was granted and assigned to Rxi Pharmaceuticals Corporation on May, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9963702 RNA interference in dermal and fibrotic indications
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.